亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

隨州佳科醫藥化工有限公司銷售二部  

原料及中間體、精細化工、涂料等產品科研、開發、生產、銷售為主的高科技企業,公司擁有自主貨物進出口權

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:高飛
  • 電話:0722-3632989
  • QQ:2286801987
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 培美曲塞二鈉@CAS150399-23-8@谷氨酸二鈉供應商
培美曲塞二鈉@CAS150399-23-8@谷氨酸二鈉供應商
單價 面議對比
詢價 暫無
發貨 湖北隨州市付款后24小時內
庫存 1000公斤起訂1公斤
品牌 佳科
型號 CAS150399-23-8
過期 長期有效
更新 2020-12-22 09:17
 
詳細信息


培美曲塞二鈉 150399-23-8

基本信息
英文名 Pemetrexed disodium
別名 N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid disodium salt
產品名稱 培美曲塞二鈉; N-[4-[2-(2-氨基-4,7-二氫-4-氧代-1H-吡咯[2,3-d]嘧啶-5-基)乙基]苯甲酰]-L-谷氨酸二鈉

分子結構

分子式 C20H19N5Na2O6
分子量 471.37
CAS 登錄號 150399-23-8

©2025 隨州佳科醫藥化工有限公司銷售二部 版權所有   技術支持:化工網   訪問量:9987  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |